{
  "type": "hyp",
  "text": "Sunitinib induces apoptosis in p53-deficient MCF-7 cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. Sunitinib is an oral multitargeted receptor tyrosine kinase inhibitor with antiangiogenic and antitumor activity that mainly targets vascular endothelial growth factor receptors (VEGFRs).\n",
  "self": {
    "NER": {
      "answers": [
        "p53-deficient MCF-7",
        "Akt",
        "Sunitinib"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of cells does sunitinib induce apoptosis in?",
          "What is the main pathway that Sunitinib inhibits?",
          "What is the name of the drug that inhibits apoptosis in p"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "apoptosis",
        "p53-deficient MCF-7 cells",
        "VEGFR2/Akt/mTOR/S6K1 pathways",
        "modulation",
        "Bcl-2 and BAD",
        "Sunitinib",
        "an oral multitargeted receptor tyrosine kinase inhibitor",
        "antiangiogenic and antitumor activity",
        "vascular endothelial growth factor receptors",
        "VEGFRs"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What does sunitinib induce in p53-deficient MCF-7 cells",
          "What type of cells does sunitinib induce apoptosis in?",
          "What does sunitinib inhibit?",
          "What does Sunitinib do to the Bcl-2 and BAD pathways?",
          "What two pathways does sunitinib inhibit?",
          "What is the name of the drug that inhibits apoptosis in p",
          "What is sunitinib?",
          "What is the main benefit of sunitinib?",
          "What does sunitinib mainly target?",
          "What does sunitinib target?"
        ]
      }
    }
  },
  "asked": {
    "What pathways does sunitinib inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "VEGFR2/Akt/mTOR/S6K1",
        "answerability": 0.9882321953773499,
        "ground_truth": {
          "Akt/mTOR/S6K1": {
            "bertscore": 0.8952491283416748,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the drug that inhibits the apoptosis pathway in": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Sunitinib",
        "answerability": 0.9049691557884216,
        "ground_truth": {
          "Sunitinib": {
            "bertscore": 1.000000238418579,
            "f1": 1.0
          }
        }
      }
    },
    "What does sunitinib induce in pheochromocytoma tumor": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "apoptosis",
        "answerability": 0.6096956729888916,
        "ground_truth": {
          "apoptosis": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What type of tumors does sunitinib induce apoptosis in": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "p53-deficient MCF-7 cells",
        "answerability": 0.9054936766624451,
        "ground_truth": {
          "pheochromocytoma tumor cells": {
            "bertscore": 0.7065920233726501,
            "f1": 0.3333333333333333
          }
        }
      }
    },
    "What does sunitinib inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "VEGFR2/Akt/mTOR/S6K1 pathways",
        "answerability": 0.9687513709068298,
        "ground_truth": {
          "VEGFR2/Akt/mTOR/S6K1 pathways": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is the mechanism by which Sunitinib inhibits the VEGFR2/Akt": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "modulation of Bcl-2 and BAD",
        "answerability": 0.9456503987312317,
        "ground_truth": {
          "modulation": {
            "bertscore": 0.7335468530654907,
            "f1": 0.33333333333333337
          }
        }
      }
    },
    "What two pathways does sunitinib inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "VEGFR2/Akt/mTOR/S6K1",
        "answerability": 0.9765700697898865,
        "ground_truth": {
          "Bcl-2 and BAD": {
            "bertscore": 0.7119458317756653,
            "f1": 0
          }
        }
      }
    },
    "What is sunitinib?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "an oral multitargeted receptor tyrosine kinase inhibitor",
        "answerability": 0.973913848400116,
        "ground_truth": {
          "an oral multitargeted receptor tyrosine kinase inhibitor": {
            "bertscore": 1.000000238418579,
            "f1": 1.0
          }
        }
      }
    },
    "What is the main benefit of sunitinib?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "mainly targets vascular endothelial growth factor receptors",
        "answerability": 0.9024798274040222,
        "ground_truth": {
          "antiangiogenic and antitumor activity": {
            "bertscore": 0.6860353350639343,
            "f1": 0
          }
        }
      }
    },
    "What does sunitinib target?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "vascular endothelial growth factor receptors",
        "answerability": 0.9777831435203552,
        "ground_truth": {
          "vascular endothelial growth factor receptors": {
            "bertscore": 1.0,
            "f1": 1.0
          },
          "VEGFRs": {
            "bertscore": 0.6769439578056335,
            "f1": 0
          }
        }
      }
    }
  }
}